SGK2

Across TCGA pan-cancer cohorts, SGK2 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SGK2 data layer compared with 19 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher SGK2 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated SGK2 expression acts as an unfavorable survival marker, although some lineages such as PDAC show a favorable association.

PDAC and CCRCC are the cancer types where SGK2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Quartile	All	0.876	0.344	.001	19	view →
CCRCC	DFS	Tertile	IV	0.198	0.887	.024	15	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SGK2–PDAC (OS)

Open the PDAC breakdown →